3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
163
Endometrial Neoplasms
13
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
5
Recurrence
4
Neoplasms
4
Neoplasm Metastasis
4
Carcinoma, Intraductal, Noninfiltrating
4
Triple Negative Breast Neoplasms
3
Breast Diseases
3
Breast Cancer Metastatic
3
Prostatic Neoplasms
2
Leiomyosarcoma
2
Carcinoma, Lobular
2
Advanced Breast Cancer
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Polycystic Ovary Syndrome
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Pain
1
Osteoporosis
1
Neoplastic Cells, Circulating
1
Neoadjuvant Operable Breast Cancer
1
Multiple Endocrine Neoplasia Type 1
1
Medullary cystic kidney disease 1
1
Lymphangioleiomyomatosis
1
Interventions
Cisplatin
68
Paclitaxel
32
Radiotherapy
31
Carboplatin
23
Bevacizumab
21
pembrolizumab
20
Brachytherapy
18
atezolizumab
11
camrelizumab
10
Nivolumab
10
Gemcitabine
10
Drug Therapy
9
tislelizumab
8
Topotecan
8
Taxes
8
Chemoradiotherapy
8
Radiation
7
Docetaxel
7
Albumin-Bound Paclitaxel
7
zimberelimab
6
toripalimab
6
nimotuzumab
6
Magnetic Resonance Spectroscopy
6
Cetuximab
6
lenvatinib
5
durvalumab
5
dostarlimab
5
Platinum
5
Papillomavirus Vaccines
5
Injections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Uterine Cervical Neoplasms
×
Letrozole
×
Clear all
NCT02482740
2015-06-26
TGOG1005
Buddhist Tzu Chi General Hospital
Phase 2
Unknown
44 enrolled